Advisornet Financial’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Advisornet Financial’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-194	Closed	-$4K	–	2194
2021 Q3	$4K	Hold	194	–	–	﹤0.01%	1685
2021 Q2	$7K	Buy	+194	New	+$5.95K	﹤0.01%	1523

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Advisornet Financial's DRNA Position: Q4 2021 in Review

Advisornet Financial sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 194 shares — an estimated $4K sold.

Advisornet Financial first reported a position in DRNA in Q2 2021 and held it in 2 quarters. The position peaked at $7K in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Advisornet Financial reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Advisornet Financial sold 194 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $4K.
Advisornet Financial first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2021 and held it in 2 quarters.
Advisornet Financial's Dicerna Pharmaceuticals, Inc. position peaked at $7K in Q2 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Advisornet Financial's 13F filing for Q4 2021, filed 19 Jan 2022.